| scholarly article | Q13442814 |
| P50 | author | Michael Katze | Q21062265 |
| Kathie-Anne Walters | Q87746084 | ||
| P2093 | author name string | Sean Proll | |
| Michael A Joyce | |||
| Norman M Kneteman | |||
| Lin-Fu Zhu | |||
| Matthew M Yeh | |||
| D Lorne Tyrrell | |||
| Maria W Smith | |||
| T J Gao | |||
| Jill C Thompson | |||
| P2860 | cites work | Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein | Q22010192 |
| Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication | Q24302046 | ||
| Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector | Q24316159 | ||
| Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I | Q24556673 | ||
| A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood | Q24614744 | ||
| Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients | Q43507370 | ||
| Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection | Q43795944 | ||
| Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers | Q44409476 | ||
| Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis | Q45736423 | ||
| Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation | Q45740469 | ||
| Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group | Q45747079 | ||
| Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis | Q45763095 | ||
| Chronic hepatitis. An update on terminology and reporting. | Q53635198 | ||
| Differential gene expression between chronic hepatitis B and C hepatic lesion | Q73570992 | ||
| Natural history of recurrent hepatitis C | Q78321473 | ||
| Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes | Q24683425 | ||
| Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation | Q27469500 | ||
| Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients | Q27469825 | ||
| DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection | Q27469850 | ||
| Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 | ||
| Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo | Q27473043 | ||
| Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis | Q27473268 | ||
| Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro | Q27473436 | ||
| Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation | Q27485763 | ||
| Minimum information about a microarray experiment (MIAME)-toward standards for microarray data | Q27860569 | ||
| The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor | Q28238069 | ||
| Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease | Q28594192 | ||
| Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF | Q29547901 | ||
| Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling | Q29614206 | ||
| Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease | Q29614208 | ||
| Evasion of intracellular host defence by hepatitis C virus | Q29618976 | ||
| Hepatitis C virus replication in mice with chimeric human livers | Q29620650 | ||
| Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis | Q33801352 | ||
| The immunopathogenesis of hepatitis C virus infection | Q34422751 | ||
| Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation | Q34792600 | ||
| Oxidative stress in viral and alcoholic hepatitis | Q35033336 | ||
| Natural history and management of hepatitis C infection after liver transplantation | Q35877930 | ||
| Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera | Q36080603 | ||
| Steatosis and chronic hepatitis C virus infection: mechanisms and significance. | Q36197552 | ||
| Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees | Q37683158 | ||
| Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers | Q38347525 | ||
| Histopathology of Hepatitis C Virus Infection | Q40435912 | ||
| Pathology of hepatitis C. | Q40702880 | ||
| Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism | Q40709438 | ||
| Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus | Q42983787 | ||
| Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group | Q42983830 | ||
| Is there a correlation between degree of viremia and liver histology in chronic hepatitis C? | Q42988562 | ||
| Hepatitis C virus population analysis of a single-source nosocomial outbreak reveals an inverse correlation between viral load and quasispecies complexity | Q42988964 | ||
| Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy | Q42990371 | ||
| Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study | Q42996072 | ||
| Serum lipid pattern in chronic hepatitis C: histological and virological correlations | Q42997238 | ||
| Identification of a specific gene expression pattern associated with HCV-induced pathogenesis in HCV- and HCV/HIV-infected individuals | Q42999233 | ||
| Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. | Q43035720 | ||
| Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells | Q43036511 | ||
| Hepatitis C virus kinetics during and immediately after liver transplantation. | Q43036834 | ||
| Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. | Q43042512 | ||
| Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis | Q43048093 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P304 | page(s) | e59 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response | |
| P478 | volume | 2 |
| Q40527893 | A proautophagic antiviral role for the cellular prion protein identified by infection with a herpes simplex virus 1 ICP34.5 mutant |
| Q34055909 | Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication |
| Q34039791 | An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones |
| Q35012721 | Animal models for studying hepatitis C and alcohol effects on liver |
| Q37843841 | Dendritic cells in hepatitis C infection: can they (help) win the battle? |
| Q35185501 | Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. |
| Q44881630 | Effect of Hepatitis C Virus Infection on the mRNA Expression of Drug Transporters and Cytochrome P450 Enzymes in Chimeric Mice with Humanized Liver |
| Q39437753 | Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. |
| Q34996679 | Experimental models for hepatitis C viral infection |
| Q34231846 | Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties |
| Q33826997 | Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus |
| Q27487541 | Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes |
| Q27487963 | HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice |
| Q66678745 | HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response |
| Q37945172 | HCV animal models: a journey of more than 30 years |
| Q33750016 | Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. |
| Q38125192 | Hepatitis C virus infection and related liver disease: the quest for the best animal model |
| Q34009002 | Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse |
| Q35034273 | Hepatitis C virus-induced cytoplasmic organelles use the nuclear transport machinery to establish an environment conducive to virus replication |
| Q41844055 | IFITM1 is a tight junction protein that inhibits hepatitis C virus entry |
| Q26864485 | Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization |
| Q37226509 | Innate immune modulation by RNA viruses: emerging insights from functional genomics |
| Q38086755 | Innate immune responses to hepatitis C virus |
| Q35893868 | Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice |
| Q36014611 | Lost in the world of functional genomics, systems biology, and translational research: is there life after the Milstein award? |
| Q27486807 | Mouse models for the study of HCV infection and virus–host interactions |
| Q52718963 | Murine Models of Hepatitis A Virus Infection. |
| Q36841728 | New animal models for hepatitis C viral infection and pathogenesis studies |
| Q36255920 | Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver |
| Q28482494 | Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture |
| Q36489340 | Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus |
| Q40096322 | Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain |
| Q93332846 | Prion Protein PRNP: A New Player in Innate Immunity? The Aβ Connection |
| Q89563089 | Prion protein PrP nucleic acid binding and mobilization implicates retroelements as the replicative component of transmissible spongiform encephalopathy |
| Q52840129 | Projection of exposure and efficacious dose prior to first-in-human studies: how successful have we been? |
| Q40250013 | Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment |
| Q33563711 | The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons |
| Q27306083 | Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes |
| Q30363963 | Use of functional genomics to understand influenza-host interactions. |
| Q27488407 | Using high-throughput genomics to study hepatitis C: What determines the outcome of infection? |
Search more.